Latest filing published 18 Dec 2018 for Swedish Orphan Biovitrum AB (publ), €54k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Emily Chamberlain: trading record in brief
Emily Chamberlain is a declared insider of Swedish Orphan Biovitrum AB (publ), with filings sourced from Finansinspektionen. We count 2 filings, every one of them for a trade on 18 December 2018.
In open-market terms, that means 1 purchase worth €21k on one side and 1 sale worth €54k on the other. On balance, insiders were net sellers of €33k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 18 December 2018, the filings show an open-market sale worth €54k in Swedish Orphan Biovitrum AB (publ). The last insider purchase was made public on 18 December 2018, 2,883 days ago. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Emily Chamberlain
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,926 shares@ SEK 190.7071.8% of flowAktieISIN SE0000872095FI:csv-9d55190e9e6bd14e3e7e
- 1,150 shares@ SEK 190.6028.2% of flowAktieISIN SE0000872095FI:csv-2f8693d5e42086675f84Canonical exit: 18 Mar 2019 (T+90)
2 of 2 declarations